GlobalData provides unique and market-leading data and insights into the pharmaceuticals market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

NEW Canada – Healthcare, Regulatory and Reimbursement Landscape

  • $1,995
  • January 2022
GlobalData, the industry analysis specialist, has released its latest report: “Canada - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare,...

NEW T-Cell Lymphomas: Epidemiology Forecast to 2030

  • $3,995
  • January 2022
TCL are a rare type of cancer that form in T-cells and are either indolent (slow-growing) or aggressive. TCL either develops in lymphoid tissues such as the lymph nodes and...

Australia – Healthcare, Regulatory and Reimbursement Landscape

  • $1,995
  • December 2021
GlobalData, the industry analysis specialist, has released its latest report: “Australia - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare,...

Duchenne Muscular Dystrophy – Opportunity Assessment and Forecast to 2030

  • $6,995
  • December 2021
Duchenne muscular dystrophy (DMD) is a rare genetic disorder characterized by progressive muscle degeneration and weakness due to the alterations of a protein called dystrophin. Dystrophin is part of a...

Endometriosis – Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • December 2021
Endometriosis is a disease characterized by the presence of endometrial-like tissue outside of the uterus. This results in chronic pelvic pain and can have significant effects on sufferers’ quality of...

Hemophilia A and B – Global Drug Forecast and Market Analysis, 2021-2030

  • $10,995
  • December 2021
Hemophilia A and B are rare disorders in coagulation, characterized by the failure of blood to form normal clots after damage to veins and tissue. The patient population is increasing...

Brain Cancer – Epidemiology Forecast to 2030

  • $3,995
  • December 2021
Primary brain cancer (ICD-10 = C70, C71, C72) is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord,...

Russia – Healthcare, Regulatory and Reimbursement Landscape

  • $1,995
  • December 2021
GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Russia”. The report is an essential source of information on analysis of the...

Chronic Myeloid Leukemia (CML): Global Drug Forecast and Market Analysis to 2030

  • $10,995
  • December 2021
Chronic myeloid leukemia (CML) is a myeloproliferative cancer resulting from the formation of an abnormal gene; BCR-ABL1. Although CML is now highly survivable due to the availability of multiple effective...

Chronic Myeloid Leukemia: Epidemiology Forecast to 2030

  • $3,995
  • December 2021
Chronic myeloid leukemia (CML) (ICD-10 = C92.1) is a rare cancer of the white blood cells characterized by increased and unregulated growth of myeloid cells originating in the bone marrow...